Detections of Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Following the 2020 Outbreak in Wild Lagomorphs across the Western United States. [PDF]
Ringenberg JM+3 more
europepmc +1 more source
Rabbit Hemorrhagic Disease Virus in Mexico in 2020-2021: Risk Areas and Climatic Distribution. [PDF]
Lorenzo C+4 more
europepmc +1 more source
Practical Suggestions for Assessing Rabbit Haemorrhagic Disease Virus 2 Risk to Endangered Native Lagomorphs in North America and Southern Africa. [PDF]
Cooke B.
europepmc +1 more source
Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits. [PDF]
Bosco-Lauth AM+10 more
europepmc +1 more source
Coding-complete genome sequences of rabbit hemorrhagic disease virus type 2 detected in 2023 in Washington State indicate a divergent incursion into the United States. [PDF]
Pauszek SJ+8 more
europepmc +1 more source
Effects of oxidative stress on viral infections: an overview. [PDF]
Kayesh MEH+2 more
europepmc +1 more source
Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant. [PDF]
Akache B, McCluskie MJ.
europepmc +1 more source
Serological characterisation of Lagovirus virus-like particles originating from native and mutated VP60 of rabbit haemorrhagic disease virus 2 and European brown hare syndrome virus. [PDF]
Krejmer-Rąbalska M+3 more
europepmc +1 more source
Characterisation of Lagovirus europaeus GI-RHDVs (Rabbit Haemorrhagic Disease Viruses) in Terms of Their Pathogenicity and Immunogenicity. [PDF]
Tokarz-Deptuła B+4 more
europepmc +1 more source
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response. [PDF]
Ning W+5 more
europepmc +1 more source